Source: Archives of Gynecology and Obstetrics. Unidade: FMRP
Subjects: IMUNOTERAPIA, SEGURANÇA DO PACIENTE, LINFÓCITOS, COVID-19, SURTOS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Marcelo Borges et al. Reply to letter to the editor. [Carta]: "Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China". Archives of Gynecology and Obstetrics. Heidelberg: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s00404-020-05830-w. Acesso em: 17 out. 2024. , 2021APA
Cavalcante, M. B., Sarno, M., Araujo Júnior, E., Costa, F. da S., & Barini, R. (2021). Reply to letter to the editor. [Carta]: "Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China". Archives of Gynecology and Obstetrics. Heidelberg: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1007/s00404-020-05830-wNLM
Cavalcante MB, Sarno M, Araujo Júnior E, Costa F da S, Barini R. Reply to letter to the editor. [Carta]: "Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China" [Internet]. Archives of Gynecology and Obstetrics. 2021 ; 304 571-572.[citado 2024 out. 17 ] Available from: https://doi.org/10.1007/s00404-020-05830-wVancouver
Cavalcante MB, Sarno M, Araujo Júnior E, Costa F da S, Barini R. Reply to letter to the editor. [Carta]: "Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China" [Internet]. Archives of Gynecology and Obstetrics. 2021 ; 304 571-572.[citado 2024 out. 17 ] Available from: https://doi.org/10.1007/s00404-020-05830-w